Internal Medicine, Erasmus Hospital, Brussels, Belgium
Geriatrics, Brugmann University Hospital, Brussels, Belgium.
BMJ Case Rep. 2021 Jun 23;14(6):e241067. doi: 10.1136/bcr-2020-241067.
Intravascular large B-cell lymphoma (IVLBCL) is an aggressive and rare type of diffuse extranodal B-cell lymphoma. Diagnosis and treatment are challenging and clinical presentation is variable. Physicians should be aware of this rare but life-threatening lymphoma without adenopathy and treatment should be promptly started. We describe the case of a 70-year-old woman who presented with general malaise, acute dyspnoea, platypnoea and lactic acidosis. Echocardiography revealed an extracardiac shunt, the cause of her orthodeoxia. The patient developed rapid liver failure and underwent liver biopsy. Anatomopathological findings suggested IVLBCL, non-germinal center type. She achieved complete remission after rituximab, cyclophosphamide, doxorubicin, vincristine, methylprednisolone chemotherapy but relapsed 1 year after initial presentation with multiple organ involvement. The patient's relapsed disease was treated with rituximab, iphosphamide, carboplatin, etoposide and she is still in complete remission 2 years later.
血管内大 B 细胞淋巴瘤(IVLBCL)是一种侵袭性和罕见的弥漫性结外 B 细胞淋巴瘤。诊断和治疗具有挑战性,临床表现多样。医生应该意识到这种罕见但危及生命的无淋巴结病淋巴瘤,治疗应迅速开始。我们描述了一位 70 岁女性的病例,她表现为全身不适、急性呼吸困难、平板呼吸和乳酸性酸中毒。超声心动图显示心外分流,这是她发生正性呼吸缺氧的原因。患者迅速出现肝功能衰竭,并进行了肝活检。病理发现提示非生发中心型 IVLBCL。她在接受利妥昔单抗、环磷酰胺、多柔比星、长春新碱、甲泼尼龙化疗后达到完全缓解,但在初次发病 1 年后出现多器官受累复发。患者的复发性疾病采用利妥昔单抗、异环磷酰胺、卡铂、依托泊苷治疗,2 年后仍处于完全缓解状态。